Company: HRTX
Filing Date: 2025-08-08
Form Type: 8-K
Source: 0000950170-25-105474
Chunk: 3

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-08-08
Form: 8-K
Item: Item 1.01
Chunk 3
---
 the public should look to other disclosures contained in the Company’s filings with the U. S. Securities and Exchange Commission.

Item 2.02 Results of Operations and Financial Condition.

On August 8, 2025, the Company issued a press release announcing its financial results for the three and six months ended June 30, 2025 (“ Earnings Press Release”). A copy of the Earnings Press Release is furnished as Exhibit 99.1.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

To the extent required by Item 2.03 of Form 8-K, the information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference.

Item 3.02 Unregistered Sale of Equity Securities

To the extent required by Item 3.02 of Form 8-K, the information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference.